NEW YORK (GenomeWeb News) – Swiss analytical services company Biolytix has bought an Affymetrix GeneChip instrument and has signed a service provider agreement with Affymetrix UK, Biolytix said today.
 
The company plans to use the GeneChip platform to offer exon and tiling arrays and SNP genotyping and gene-mapping arrays that could be used in transcriptome mapping, gene regulation, genome-wide SNP mapping, and re-sequencing.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.